Compare · ATKR vs TMO
ATKR vs TMO
Side-by-side comparison of Atkore Inc. (ATKR) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- ATKR operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $174.42B, about 65.2x ATKR ($2.68B).
- Over the past year, ATKR is up 19.8% and TMO is up 15.8% - ATKR leads by 3.9 points.
- ATKR has been more active in the news (17 items in the past 4 weeks vs 6 for TMO).
- TMO has more recent analyst coverage (25 ratings vs 14 for ATKR).
- Company
- Atkore Inc.
- Thermo Fisher Scientific Inc
- Price
- $79.14+0.13%
- $469.39-1.33%
- Market cap
- $2.68B
- $174.42B
- 1M return
- +4.60%
- +5.22%
- 1Y return
- +19.76%
- +15.83%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 2016
- News (4w)
- 17
- 6
- Recent ratings
- 14
- 25
Atkore Inc.
Atkore Inc. manufactures and distributes electrical raceway products, and mechanical products and solutions (MP&S) in the United States and internationally. The company offers electrical raceway products, including electrical conduits and fittings, armored cables and fittings, and cable trays and mounting systems and fittings. It also provides MP&S products comprising metal framing and fittings, mechanical pipes, and barbed tapes, as well as construction services related to design, fabrication and installation, modular support structures, and fall protection. The company offers its products under the Allied Tube & Conduit, AFC Cable Systems, Heritage Plastics, Unistrut, Power-Strut, Cope, and Calpipe brands, as well as other sub-brands. It serves a group of end markets, including new construction; maintenance, repair, and remodel, as well as infrastructure; diversified industrials; alternative power generation; healthcare; data centers; and government through electrical, industrial, and mechanical contractors, as well as original equipment manufacturers. The company was formerly known as Atkore International Group Inc. and changed its name to Atkore Inc. in February 2021. Atkore Inc. was founded in 1959 and is headquartered in Harvey, Illinois.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest ATKR
- Director Edmonds Franklin S. Jr. was granted 11 shares, increasing direct ownership by 0.40% to 2,834 units (SEC Form 4)
- Director Wynn Betty R. was granted 31 shares, increasing direct ownership by 0.15% to 20,588 units (SEC Form 4)
- Director Zeffiro A Mark was granted 54 shares, increasing direct ownership by 0.23% to 23,945 units (SEC Form 4)
- Pres. Safety & Infrastructure Lamps Mark F. was granted 53 shares, increasing direct ownership by 0.15% to 36,103 units (SEC Form 4)
- VP, General Counsel and Sec. Kelly Daniel S was granted 41 shares, increasing direct ownership by 0.13% to 32,630 units (SEC Form 4)
- Director Edwards Barbara Joanne was granted 20 shares, increasing direct ownership by 0.34% to 6,081 units (SEC Form 4)
- Director James Wilbert W Jr was granted 68 shares, increasing direct ownership by 0.40% to 17,131 units (SEC Form 4)
- Director Isbell Jeri L was granted 110 shares, increasing direct ownership by 0.36% to 30,558 units (SEC Form 4)
- President and CEO Waltz William E Jr. was granted 272 shares, increasing direct ownership by 0.22% to 123,411 units (SEC Form 4)
- VP, CFO Deitzer John Michael was granted 53 shares, increasing direct ownership by 0.28% to 18,881 units (SEC Form 4)
Latest TMO
- Piper Sandler initiated coverage on Thermo Fisher with a new price target
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)